Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia.
Clinical trial NCT05123755 · RECRUITING
Trial details
- NCT number
- NCT05123755
- Sponsor
- Vasomune Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-20
- Primary completion
- 2026-05-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.